The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction-Reference-Cited by-同舟云学术

The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction

Published:2017-04 Issue:4 Volume:66 Page:724-733
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Schwabl Philipp,Hambruch Eva,Seeland Berit A.,Hayden Hubert,Wagner Michael,Garnys Lukas,Strobel Bastian,Schubert Tim-Lukas,Riedl Florian,Mitteregger Dieter,Burnet Michael,Starlinger Patrick,Oberhuber Georg,Deuschle Ulrich,Rohr-Udilova Nataliya,Podesser Bruno K.,Peck-Radosavljevic Markus,Reiberger Thomas,Kremoser Claus,Trauner Michael

Publisher

Elsevier BV

Subject

Hepatology

Reference63 articles.

1. Hepatic fibrosis: Concept to treatment;Trautwein;J Hepatol,2015

2. Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension;Mandorfer;J Hepatol,2016

3. Collagen proportionate area is superior to other histological methods for sub-classifying cirrhosis and determining prognosis;Tsochatzis;J Hepatol,2014

4. Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension;Kim;J Hepatol,2011

5. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis;Ripoll;Gastroenterology,2007

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sequential system based on ferritin delivery system and cell therapy for modulating the pathological microenvironment and promoting recovery;International Journal of Pharmaceutics;2024-10

2. Imperatorin attenuates CCl4-induced cirrhosis and portal hypertension by improving vascular remodeling and profibrogenic pathways;European Journal of Pharmacology;2024-10

3. Angiocrine signaling in sinusoidal homeostasis and liver diseases;Journal of Hepatology;2024-09

4. Microbiota alterations associated with vascular diseases: postbiotics as a next-generation magic bullet for gut-vascular axis;Pharmacological Research;2024-09

5. Gut microbiota and metabolites of cirrhotic portal hypertension: a novel target on the therapeutic regulation;Journal of Gastroenterology;2024-07-19